SCHEMBL6792426

SCHEMBL6792426

COc1cc(/C=C/C=C/C(=O)N2CCN(C(=O)/C=C/C=C/c3cc(OC)c(OC(C)C)c(OC)c3)CC2)cc(OC)c1OC(C)C

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.57
ALDH1A1 P00352 5/20 0.57
HPGD P15428 3/20 0.57
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
ATM Q13315 1/20 0.47
ABCB1 P08183 1/20 0.46
ALOX5 P09917 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
TRPV1 Q8NER1 3/20 0.44
STAT6 P42226 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783016 0.96 KDM4E (0.60) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL5572618 0.89 KDM4E (0.53) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL5572621 0.89 KDM4E (0.53) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL6785121 0.88 ALDH1A1 (0.72) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL6785718 0.85 ALDH1A1 (0.76) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL5573123 0.83 KDM4E (0.59) KDM4EALDH1A1HPGDL3MBTL1ABCB1
SCHEMBL5573125 0.83 KDM4E (0.59) KDM4EALDH1A1HPGDL3MBTL1ABCB1
SCHEMBL25309070 0.82 ALDH1A1 (0.80) KDM4EALDH1A1HPGDKMT2AMEN1
SCHEMBL10867366 0.82 ALDH1A1 (0.57) KDM4EALDH1A1HPGDL3MBTL1KMT2A
SCHEMBL5570650 0.81 KDM4E (0.63) KDM4EALDH1A1HPGDL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 KDM4E 562/4885ALDH1A1 836/4885HPGD 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.